WallStreetZenWallStreetZen

How to Buy Biogen Stock

Biogen Inc

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases.

Biogen stock last closed at $230.63, up 2.17% from the previous day, and has decreased 26.41% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.49 percentage points. Biogen stock is currently +21.74% from its 52-week low of $189.44, and -24.76% from its 52-week high of $306.52.

As of Jun 12, 2024, there are 145.6M BIIB shares outstanding. The market value of BIIB is $33.58B. In the past 24 hours, 1.03M BIIB shares were traded.

How to Buy Biogen Stock

Not sure how to invest in Biogen stock? Here's how.
  1. Decide where to buy Biogen stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Biogen stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your brokerage account: Choose your payment method and add your info.
  4. Analyze Biogen stock: The Biogen ticker symbol is BIIB. Is Biogen stock a good investment? Should you buy shares of BIIB? How do BIIB's underlying business fundamentals look? Do top analysts think Biogen is a good buy? Why has BIIB's stock price moved recently? (Hint: Our stock research tools can help you understand if BIIB is a good stock to buy).
  5. Place your BIIB trade: Decide if you will purchase BIIB shares at the current market price or use a limit order to purchase BIIB shares at a specific price.
  6. Watch your BIIB investment: Create a watchlist to track your new investment in Biogen stock.

Step 1: Decide where to buy Biogen stock

You will need an online brokerage account in order to access the NASDAQ market and buy BIIB shares.

A brokerage account allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best stock brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can invest in BIIB today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start a new trading account.
  1. Send your data by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you've filled out your info on the stocks app, you need to deposit funds:

Check out the walkthrough below to see the process of transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Biogen stock

After you have decided on the best place to buy Biogen stock, it's crucial to analyze their stock before you invest, so you can wrap your head around the risk as well as the opportunity.

Biogen stock data

BIIB Price
$230.63
1w %
-2.57%
1y %
-26.41%
5y %
0.09%
P/E
28.65x
P/B
2.21x
P/S
3.47x
PEG
0.85x
Revenue
$9.66B
Earnings
$1.17B
Fore. Rev. Growth
0.47%
Fore. Earn. Growth
33.6%
Market Cap
$33.58B
Next Earnings
Jun 20, 2024
Next Dividend
N/A

BIIB Overview

WallStreetZen was built to help part-time investors do better fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on BIIB's stock page.

Is BIIB stock undervalued?

Investors use many financial metrics, analyses, models, and charts to gauge BIIB's intrinsic value.

Using relative valuations metrics:

  • BIIB could be undervalued based on its P/E ratio of 28.65x, relative to Drug Manufacturers - General industry P/E ratio of 39.95x
  • BIIB could be undervalued based on its P/B ratio of 2.21x, relative to Drug Manufacturers - General industry P/B ratio of 6.54x
  • BIIB may be undervalued based on its PEG ratio of 0.85x

You can do additional valuation research on BIIB's stock here.

BIIB Financials at a glance

Pros:

  • There are more short-term assets than short-term liabilities on the BIIB balance sheet.
  • Total BIIB debt is lower than 5 years ago, relative to shareholder equity.
  • BIIB's operating cash flow of $1.65B allows it to safely service it's debt of $6.95B.
  • BIIB earnings of $1.32B is not sufficient to cover its interest payments.

Cons:

  • BIIB profit margin has gone down from 31% to 12.1% in the past year.
  • BIIB has a relatively high debt to equity ratio of 0.75.
  • There are more long-term liabilities than short-term assets on the BIIB balance sheet.

Is it a good time to buy Biogen stock, according to analysts?

Out of 19 Wall Street analysts who track BIIB, the consensus analyst rating on Biogen is a Buy

It's important to note that analyst forecasts are not recommendations, nor are they financial advice.

Most Recent BIIB Analyst Ratings

Jay Olson, a top 2% analyst from Oppenheimer maintains BIIB with a buy rating and maintains their BIIB price target from $270.00 to $270.00, on Apr 29, 2024.

Carter Gould, a top 16% analyst from Barclays maintains BIIB with a hold rating and lowers their BIIB price target from $215.00 to $200.00, on Apr 25, 2024.

Laura Chico, a top 26% analyst from Wedbush maintains BIIB with a hold rating and raises their BIIB price target from $213.00 to $215.00, on Apr 25, 2024.

Colin Bristow, a bottom 10% analyst from UBS maintains BIIB with a hold rating and lowers their BIIB price target from $250.00 to $214.00, on Apr 17, 2024.

Geoff Meacham, a bottom 5% analyst from Bank of America maintains BIIB with a hold rating and lowers their BIIB price target from $280.00 to $260.00, on Apr 12, 2024.

You can dig deeper into what analysts are forecasting on the Biogen stock forecast page.

BIIB Momentum

SMA10
228.54
SMA20
226.74
SMA50
215.38
SMA100
221.77
SMA200
235.97
MACD
3.04
MACD Signal
3.28
MACD Histogram
-0.24
RSI
57.44
Stochastic %K
62.92
Stochastic %D
61.22
StochRSI %K
46.22
StochRSI %D
44.06

BIIB Earnings

Last year, BIIB earnings were $1.17B. During the last 5 year, BIIB's earnings have grown by -19.14% per year. This was slower than the Drug Manufacturers - General industry average of 0.54%.

Last year, BIIB revenue was $9.66B. During the past five year, BIIB's revenue has gone up by -6.89% per year. This was slower than the Drug Manufacturers - General industry average of 7.49%.

Dive into BIIB's earnings and revenue performance here.

Who is buying/selling BIIB?

Over the past year, executives and large shareholders at BIIB have sold more shares than they have bought.

Adam Keeney, Head of Corporate Development of BIIB, was the latest BIIB insider to sell. They sold $59,651.88 worth of BIIB shares on May 1, 2024.

Research more about who owns BIIB shares here.

Can I get consistent income from BIIB stock?

No, Biogen doesn't provide an income stream by paying out dividends.

What do other traders have to say about BIIB?

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Place your BIIB trade

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are usually sufficient.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at an exact price, use a limit order.

Press the Open Trade button and eToro will execute the order.

If you want additional help with investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Watch your BIIB investment

Now that you own some BIIB shares, you'll want to stay up-to-date on your stock purchase.

Start a watchlist to track the most important metrics related to your BIIB stock.

BIIB Feed

How to Buy Stock in Biogen

To reiterate, here are the 6 steps you need to take to buy Biogen stock right now:

  1. Decide where to buy Biogen stock
  2. Sign up for a brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Biogen stock
  5. Place your BIIB trade
  6. Watch your BIIB investment

If you are looking for a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to watch your investment in Biogen, click the button below.

NASDAQ: BIIB
$230.63+4.89 (+2.17%)
Updated Jun 12, 2024
Open eToro Account
NASDAQ: BIIB
$230.63+4.89 (+2.17%)
Updated Jun 12, 2024
Open eToro Account

FAQ

How much does it cost to buy one Biogen share?

As of Jun 12, 2024, it costs $230.63 to buy one share of Biogen stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.434 shares of BIIB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Biogen stock?

According to 19 Wall Street analysts who monitor Biogen, their consensus recommendation is to buy Biogen stock.

What is the best way to buy Biogen stock?

One way to place an order for Biogen stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.